• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肿瘤免疫微环境的免疫表型可实现阴茎癌患者的无监督分层。

Immunophenotypes Based on the Tumor Immune Microenvironment Allow for Unsupervised Penile Cancer Patient Stratification.

作者信息

Chu Chengbiao, Yao Kai, Lu Jiangli, Zhang Yijun, Chen Keming, Lu Jiabin, Zhang Chris Zhiyi, Cao Yun

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

出版信息

Cancers (Basel). 2020 Jul 4;12(7):1796. doi: 10.3390/cancers12071796.

DOI:10.3390/cancers12071796
PMID:32635549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7407624/
Abstract

The tumor immune microenvironment (TIME) plays an important role in penile squamous cell carcinoma (peSCC) pathogenesis. Here, the immunophenotype of the TIME in peSCC was determined by integrating the expression patterns of immune checkpoints (programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and Siglec-15) and the components of tumor-infiltrating lymphocytes, including CD8 or Granzyme B T cells, FOXP3 regulatory T cells, and CD68 or CD206 macrophages, in 178 patients. A high density of Granzyme B, FOXP3, CD68, CD206, PD-1, and CTLA-4 was associated with better disease-specific survival (DSS). The patients with diffuse PD-L1 tumor cell expression had worse prognoses than those with marginal or negative PD-L1 expression. Four immunophenotypes were identified by unsupervised clustering analysis, based on certain immune markers, which were associated with DSS and lymph node metastasis (LNM) in peSCC. There was no significant relationship between the immunophenotypes and high-risk human papillomavirus (hrHPV) infection. However, the hrHPV-positive peSCC exhibited a higher density of stromal Granzyme B and intratumoral PD-1 than the hrHPV-negative tumors ( = 0.049 and 0.002, respectively). In conclusion, the immunophenotypes of peSCC were of great value in predicting LNM and prognosis, and may provide support for clinical stratification management and immunotherapy intervention.

摘要

肿瘤免疫微环境(TIME)在阴茎鳞状细胞癌(peSCC)的发病机制中起着重要作用。在此,通过整合免疫检查点(程序性细胞死亡蛋白1(PD-1)/程序性细胞死亡配体1(PD-L1)、细胞毒性T淋巴细胞相关抗原4(CTLA-4)和唾液酸结合免疫球蛋白样凝集素15(Siglec-15))的表达模式以及肿瘤浸润淋巴细胞的组成部分,包括CD8或颗粒酶B T细胞、叉头框蛋白3(FOXP3)调节性T细胞以及CD68或CD206巨噬细胞,对178例患者的peSCC中的TIME免疫表型进行了测定。颗粒酶B、FOXP3、CD68、CD206、PD-1和CTLA-4的高密度与更好的疾病特异性生存(DSS)相关。弥漫性PD-L1肿瘤细胞表达的患者预后比边缘性或阴性PD-L1表达的患者更差。基于某些免疫标志物的无监督聚类分析确定了四种免疫表型,它们与peSCC的DSS和淋巴结转移(LNM)相关。免疫表型与高危人乳头瘤病毒(hrHPV)感染之间无显著关系。然而,hrHPV阳性的peSCC比hrHPV阴性肿瘤表现出更高密度的基质颗粒酶B和肿瘤内PD-1(分别为P = 0.049和0.002)。总之,peSCC的免疫表型在预测LNM和预后方面具有重要价值,并可能为临床分层管理和免疫治疗干预提供支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/2d5be1eb5447/cancers-12-01796-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/43969ae08eba/cancers-12-01796-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/c5961e29ff4f/cancers-12-01796-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/80013015d85f/cancers-12-01796-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/f244e86f654b/cancers-12-01796-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/e7e8fcdd208f/cancers-12-01796-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/2d5be1eb5447/cancers-12-01796-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/43969ae08eba/cancers-12-01796-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/c5961e29ff4f/cancers-12-01796-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/80013015d85f/cancers-12-01796-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/f244e86f654b/cancers-12-01796-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/e7e8fcdd208f/cancers-12-01796-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6658/7407624/2d5be1eb5447/cancers-12-01796-g006.jpg

相似文献

1
Immunophenotypes Based on the Tumor Immune Microenvironment Allow for Unsupervised Penile Cancer Patient Stratification.基于肿瘤免疫微环境的免疫表型可实现阴茎癌患者的无监督分层。
Cancers (Basel). 2020 Jul 4;12(7):1796. doi: 10.3390/cancers12071796.
2
The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma.肿瘤微环境中免疫因子对阴茎鳞癌预后的价值。
Front Immunol. 2018 Jun 11;9:1253. doi: 10.3389/fimmu.2018.01253. eCollection 2018.
3
Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma.肿瘤程序性死亡配体1(PD-L1)表达与阴茎鳞状细胞癌中肿瘤浸润淋巴细胞(TILs)增加及预后不良相关。
Oncoimmunology. 2016 Dec 22;6(2):e1269047. doi: 10.1080/2162402X.2016.1269047. eCollection 2017.
4
Expression of Programmed Death Ligand 1 in Penile Cancer is of Prognostic Value and Associated with HPV Status.程序性死亡配体 1 在阴茎癌中的表达具有预后价值,并与 HPV 状态相关。
J Urol. 2017 Mar;197(3 Pt 1):690-697. doi: 10.1016/j.juro.2016.09.088. Epub 2016 Sep 30.
5
Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.阴茎鳞状细胞癌中的免疫检查点状态:一个北美队列研究。
Hum Pathol. 2017 Jan;59:55-61. doi: 10.1016/j.humpath.2016.09.003. Epub 2016 Sep 20.
6
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.程序性死亡配体1(PD-L1)表达与高级别浆液性卵巢癌中的肿瘤浸润性T细胞及良好预后相关。
Gynecol Oncol. 2016 May;141(2):293-302. doi: 10.1016/j.ygyno.2016.03.008. Epub 2016 Mar 16.
7
Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma.抗 PD-1 单克隆抗体纳武利尤单抗治疗放疗和多化疗难治性晚期阴茎鳞状细胞癌的疗效证据。
J Immunother. 2018 Jul/Aug;41(6):300-305. doi: 10.1097/CJI.0000000000000221.
8
Intratumoral Cytotoxic T-Lymphocyte Density and PD-L1 Expression Are Prognostic Biomarkers for Patients with Colorectal Cancer.肿瘤内细胞毒性T淋巴细胞密度和PD-L1表达是结直肠癌患者的预后生物标志物。
Medicina (Kaunas). 2019 Oct 31;55(11):723. doi: 10.3390/medicina55110723.
9
Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma.胃腺癌中免疫检查点程序性死亡1配体1和细胞毒性T淋巴细胞相关分子4
Oncoimmunology. 2015 Nov 9;5(5):e1100789. doi: 10.1080/2162402X.2015.1100789. eCollection 2016 May.
10
Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.三阴性乳腺癌原发肿瘤与配对淋巴结转移灶中 PD-L1 表达的异质性。
BMC Cancer. 2018 Jan 2;18(1):4. doi: 10.1186/s12885-017-3916-y.

引用本文的文献

1
The prognostic role of HPV status in penile squamous cell carcinoma: a systematic review and meta-analysis.人乳头瘤病毒(HPV)状态在阴茎鳞状细胞癌中的预后作用:一项系统评价和荟萃分析
Int J Impot Res. 2025 Aug 6. doi: 10.1038/s41443-025-01145-z.
2
Emerging Advances in the Molecular Landscape of Penile Cancer and Their Implications for Precision Medicine.阴茎癌分子图谱的新进展及其对精准医学的意义。
Curr Treat Options Oncol. 2025 May;26(5):367-374. doi: 10.1007/s11864-025-01319-3. Epub 2025 Apr 16.
3
Smoking and presence of human papillomavirus correlates with lymphocyte density in the stroma of penile squamous cell carcinoma.

本文引用的文献

1
Prevalence of human papillomavirus and implication on survival in Chinese penile cancer.中国人阴茎癌中人乳头瘤病毒的流行情况及其对生存的影响。
Virchows Arch. 2020 Nov;477(5):667-675. doi: 10.1007/s00428-020-02831-7. Epub 2020 May 19.
2
Immunoscore assay for the immune classification of solid tumors: Technical aspects, improvements and clinical perspectives.免疫评分检测在实体肿瘤免疫分类中的应用:技术方面、改进及临床前景。
Methods Enzymol. 2020;636:109-128. doi: 10.1016/bs.mie.2019.07.018. Epub 2019 Oct 18.
3
Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
吸烟与人乳头瘤病毒的存在与阴茎鳞状细胞癌基质中的淋巴细胞密度相关。
Front Oncol. 2025 Mar 31;15:1568764. doi: 10.3389/fonc.2025.1568764. eCollection 2025.
4
Inflammation in Penile Squamous Cell Carcinoma: A Comprehensive Review.阴茎鳞状细胞癌中的炎症:综述
Int J Mol Sci. 2025 Mar 19;26(6):2785. doi: 10.3390/ijms26062785.
5
Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinoma.在阴茎鳞状细胞癌中,随着疾病进展,T细胞逐渐耗竭,衰老组织相关巨噬细胞占主导地位。
Sci Rep. 2025 Mar 5;15(1):7703. doi: 10.1038/s41598-025-89760-0.
6
Prognostic implications of immune classification based on PD-L1 expression and tumor-infiltrating lymphocytes in endocervical adenocarcinoma.基于PD-L1表达和肿瘤浸润淋巴细胞的免疫分类对宫颈腺癌的预后影响
Transl Oncol. 2025 Feb;52:102265. doi: 10.1016/j.tranon.2024.102265. Epub 2024 Dec 29.
7
Human papillomavirus infection affects the immune microenvironment and antigen presentation in penile cancer.人乳头瘤病毒感染会影响阴茎癌中的免疫微环境和抗原呈递。
Front Oncol. 2024 Oct 18;14:1463445. doi: 10.3389/fonc.2024.1463445. eCollection 2024.
8
HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights.人乳头瘤病毒与阴茎癌:流行病学、风险因素及临床见解
Pathogens. 2024 Sep 18;13(9):809. doi: 10.3390/pathogens13090809.
9
LncRNA sequencing reveals an essential role for the lncRNA-mediated ceRNA network in penile squamous cell carcinoma.长链非编码RNA测序揭示了长链非编码RNA介导的竞争性内源RNA网络在阴茎鳞状细胞癌中的重要作用。
Genes Immun. 2024 Dec;25(6):447-458. doi: 10.1038/s41435-024-00295-2. Epub 2024 Sep 6.
10
Advances in molecular basis of response to immunotherapy for penile cancer: better screening of responders.阴茎癌免疫治疗反应的分子基础进展:更好地筛选反应者。
Front Oncol. 2024 Jul 17;14:1394260. doi: 10.3389/fonc.2024.1394260. eCollection 2024.
吲哚胺 2,3-双加氧酶 1(IDO1)表达和催化活性的上调与阴茎鳞癌患者的免疫抑制和预后不良有关。
Cancer Commun (Lond). 2020 Jan;40(1):3-15. doi: 10.1002/cac2.12001. Epub 2020 Mar 3.
4
Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses.肿瘤相关巨噬细胞中的甘露糖受体(CD206)激活可增强适应性和先天性抗肿瘤免疫反应。
Sci Transl Med. 2020 Feb 12;12(530). doi: 10.1126/scitranslmed.aax6337.
5
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
6
Siglec-15: An Attractive Immunotherapy Target.Siglec-15:一种有吸引力的免疫治疗靶点。
Cancer Discov. 2020 Jan;10(1):7-8. doi: 10.1158/2159-8290.CD-NB2019-136. Epub 2019 Dec 5.
7
CD206 tumor-associated macrophages promote proliferation and invasion in oral squamous cell carcinoma via EGF production.CD206 肿瘤相关巨噬细胞通过产生 EGF 促进口腔鳞状细胞癌的增殖和侵袭。
Sci Rep. 2019 Oct 10;9(1):14611. doi: 10.1038/s41598-019-51149-1.
8
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer.外泌体 PD-L1 通过免疫逃避促进非小细胞肺癌肿瘤生长。
Exp Mol Med. 2019 Aug 9;51(8):1-13. doi: 10.1038/s12276-019-0295-2.
9
NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing.NK 细胞在连续杀伤过程中从颗粒酶 B 切换到死亡受体介导的细胞毒性。
J Exp Med. 2019 Sep 2;216(9):2113-2127. doi: 10.1084/jem.20181454. Epub 2019 Jul 3.
10
Combination of CTLA-4 and PD-1 blockers for treatment of cancer.CTLA-4 和 PD-1 抑制剂联合治疗癌症。
J Exp Clin Cancer Res. 2019 Jun 13;38(1):255. doi: 10.1186/s13046-019-1259-z.